Developing and commercializing peptide therapeutics for nerve regeneration: an interview with NervGen Pharma

Written by RegMedNet

Learn more about NervGen Pharma (BC, USA), a company developing innovative peptide-based therapeutics to treat spinal cord injuries. In this interview, we spoke to Jerry Silver, co-inventor and Scientific Advisor, Ernest Wong, President and CEO, and Bill Radvak, co-founder and Executive Chairman, NervGen Pharma (BC, USA) to learn more about their history, technology and journey to commercialization. Please introduce yourself and your institution. Jerry Silver (JS): I received my PhD from Case Western Reserve in 1974 and did post-doctoral work at Harvard University in the Department of Neurosciences at The Children’s Hospital and in the Neuropathology Department at Harvard Medical...

To view this content, please register now for access

It's completely free